China likely to become the biggest probiotic market by 2030, says IPA chief

While the US is still the leading probiotic market, China is quickly catching up, seeing double digit growth in the years leading up to 2026.

This upward trend could see China become the leading probiotic market in the next three years, according to George Paraskevakos, executive director at the International Probiotics Association (IPA), a trend that informed the association’s decision to open its China office and jointly launch the first Probiota Asia in partnership with NutraIngredients.

“We thought [China] was an important market to look at, not only because of the growth, but also the amount of probiotic products and the amount of probiotic companies that were there,” Paraskevakos said. “There was a lot of confusion, so we’re hoping to establish the office and emulate the success that we’ve done with IPA for probiotics in other regional markets around the world.”

European brands increasingly targeting China’s gut health market

At the country level, the United States has long been the largest probiotic market, valued at $2.6 billion in 2024, according to IPA data. China followed closely behind, with a market value of $1.9 billion.

However, at the regional level, the Asia Pacific (APAC) region came out on top, valued at $3.7 billion, followed by the Americas at $3.2 billion. APAC is also the fastest growing market, growing at a CAGR of 12.7% from 2020-2024, with the Americas growing at a CAGR of 4.3%.

In 2026, the value of APAC’s probiotic market is likely to be around $4-4.5 billion, Paraskevakos said, with China holding a 52% market share. However, while APAC’s growth has been stunted by global economic headwinds, China is still growing faster than the US and is heading towards becoming the largest global market.

Many probiotic companies have taken heed of this growth, expanding their operations across the region. European brands, in particular, are increasingly targeting China’s gut health market, driven by strong consumer trust in European clinical validation, quality control, and strain technology.

Explore related questions

Data from WPIC, a digital commerce and technology agency, shows that China has become the world’s second largest nutraceutical market overall, with the company’s chief growth officer Peter McMath noting that the ‘Made in the EU’ label is an increasingly important differentiator.

“European manufacturing carries a set of positive associations for both consumers and business partners: Clean ingredient sourcing, strong regulatory oversight and manufacturing process integrity,” he previously told NutraIngredients. “Chinese consumers also associate the European lifestyle with healthy living, which gives European supplement makers a branding advantage on top of the quality aspects.”

How brands are competing with ‘natural’, food-oriented probiotic sources

While the sector therefore presents significant opportunities, probiotic companies entering the Chinese market face a unique challenge. The widespread consumption of fermented foods and beverages means probiotic supplements must compete with established, culturally familiar sources of beneficial bacteria. However, Paraskevakos said the tide is beginning to turn.

“When I started going to China, [fermented foods] dominated how people were ingesting their microbes,” he said. “Then, right after COVID, people started to talk a lot about micro-ecological health—that was their terminology that kind of coined the overall One Health aspect that we know today. So, it’s really taken a turn, and the Chinese population has now accepted probiotics in different dosage forms, and they are looking towards probiotics for overall gut health […] it’s gained much acceptance.”

Some companies are taking a different approach, developing products that bridge the gap between conventional foods and supplements. For example, probiotics are increasingly being added to foods such such as yogurts, milk powders, milk-melt candies, jellies and cereals, according to Helen Hu, president of health and wellness for APAC at ADM.

Prebiotics and postbiotics are also gaining ground, Paraskevakos said, but the market value and general consumer awareness is lower compared to probiotics.

Education is also needed to better improve consumer understanding of the types and benefits of probiotics, he added, and the IPA hopes to introduce a verification program to guide consumers and healthcare professionals on what to look for when buying a quality probiotic product.

“Simple things like the strains, the CFU counts, expiry dates, descending order of the ingredients, stability—these are items that are very simplistic,” he said. “If we can create that elevated standard and have companies […] in China abide by it, we can have a check mark to say these products are fully verified.”